Related Experiment Video
Updated: Mar 9, 2026

16:02
Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
3.4K
Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods.
1Kevin A. Ford, PhD, DABT, is a Chemical and Computational Toxicologist in the Safety Assessment group at Genentech Inc, in South San Francisco, California.
ILAR Journal
|January 6, 2017
Summary
Computational toxicology models offer a cost-effective, rapid, and standardized alternative to animal testing for toxicity studies. These in silico methods support the 3Rs (reduce, refine, replace) by predicting potential toxicities early in compound development.
Area of Science:
- Toxicology
- Computational Biology
- Pharmacology
Background:
- Growing interest in animal welfare has led to regulations promoting the 3Rs (reduce, refine, replace) in toxicity testing.
- Alternative testing approaches are crucial for characterizing potential toxicities with minimal or no animal use.
- Computational toxicology models represent a key alternative approach.
Purpose of the Study:
- To introduce computational toxicology concepts.
- To evaluate the role of these models in compound safety assessment.
- To highlight in silico methods supporting the 3Rs.
Main Methods:
- Review of computational toxicology models and their applications.
- Evaluation of in silico methods for predicting toxicological endpoints.
- Analysis of the advantages of computational models over in vitro and in vivo methods.
Main Results:
- Computational models offer cost-effectiveness, rapid results, and standardized procedures.
- Increased use of computational models in pharmaceutical research for early toxicity screening.
- Models are available for predicting endpoints like mutagenicity, carcinogenicity, and skin sensitization with varying success.
Conclusions:
- Computational toxicology is vital for advancing the 3Rs in toxicity testing.
- In silico methods provide significant advantages for safety assessment.
- These models are increasingly integrated into drug development to screen toxic compounds.

